USA - NASDAQ:ADMP - US00547W3079 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to ADMP. The Buy consensus is the weighted average rating of the current analysts ratings.
6 analysts have analysed ADMP and the average price target is 0.43 USD. This implies a price decrease of -44.73% is expected in the next year compared to the current price of 0.7751.
The consensus rating for ADAMIS PHARMACEUTICALS CORP (ADMP) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering ADAMIS PHARMACEUTICALS CORP (ADMP) is 6.